Company / Capital Expenditures
Penumbra, Inc. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$63.7M
FY2025
5-year range
$15.2M / $63.7M
FY2021-FY2025
Trend
+200.9%
vs FY2024
Sector context
#75 of 151
Health Care
What the data says
Capital Expenditures changed +201% YoY in FY2025, a notable deviation from the 9-year average annual change of +42%.
Based on SEC 10-K filings.
$64M in FY2025 with a 5-year CAGR of +20.8%.
Improved from $15M to $64M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +37.1%
- 5-Year CAGR
- +20.8%
- 10-Year CAGR
- -
Sector benchmark
#75 of 151 in Health CareTop 50% of 151This company $63.7M Sector average $271.7M
▼
-76.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +20.8%, indicating consistent growth.
- In FY2025, capital expenditures increased 200.9% year-over-year.
- Ranks #75 out of 151 companies in the Health Care sector.
- Lowest capital expenditures in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 3.11 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $63.7M | +200.9% |
| FY2024 | $21.2M | +39.2% |
| FY2023 | $15.2M | -38.5% |
| FY2022 | $24.8M | +12.0% |
| FY2021 | $22.1M | -10.7% |
| FY2020 | $24.8M | +97.5% |
| FY2019 | $12.5M | -8.1% |
| FY2018 | $13.6M | +149.1% |
| FY2017 | $5.5M | -59.9% |
| FY2016 | $13.6M | +149.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026